Navigation Links
Aeterna Zentaris: FDA Approves Investigational New Drug (IND) Application for Doxorubicin Targeted Conjugate Compound, AEZS-108, in Bladder Cancer
Date:5/12/2010

About AEZS-108

AEZS-108 represents a new targeting concept in oncology using a cytotoxic peptide conjugate which is a hybrid molecule composed of a synthetic peptide carrier and a well-known cytotoxic agent, doxorubicin. The design of this product allows for the specific binding and selective uptake of the cytotoxic conjugate by LHRH-receptor-positive tumors. The binding of AEZS-108 to cancerous cells that express these receptors results in its accumulation and preferential uptake in the malignant tissue.

About Bladder Cancer

According to the National Cancer Institute, bladder cancer is the sixth most common type of cancer. In 2009, there were 70,980 new cases and 14,330 deaths from bladder cancer in the U.S. alone.

About Aeterna Zentaris Inc.

Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy. News releases and additional information are available at www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of b
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Aeterna Zentaris Receives Orphan-Drug Designation from the FDA for AEZS-108 in Ovarian Cancer
2. AEterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and Licensing of Cetrorelix in Benign Prostatic Hyperplasia
3. AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma
4. AEterna Zentaris Announces Appointment of New Board Member
5. AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
6. AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
7. AEterna Zentaris Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma
8. AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer
9. AEterna Zentaris Receives US$5.5 Million from Institutional Investors
10. AEterna Zentaris to Raise US$5.5 Million from Institutional Investors at US$1.20 Per Share
11. AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin (AEZS-130) as First Oral Diagnostic Test for Growth Hormone Deficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... As a leading provider of telehealth ... release of their infographic - " 8 New ... goal was to leverage an information graphic to ... 3.0 and mHealth.The infographic features a list of ... the fitness industry in unimaginable ways; turning science ...
(Date:6/18/2013)... PathoGenetix, Inc. , a commercial-stage ... strain typing, announced today that John A. Luckey, ... President of Engineering. Dr. Luckey will lead technology ... Microbial Genotyping System . The fully automated RESOLUTION ... kits, database and software, will be commercially available ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Kitware ... today announces a new Fast-Track award from the U.S. ... design-analysis environment (IDAE) for the nuclear power industry. , ... for more than 30 years, but the United States’ ... remarkable gains in power plant utilization through improved refueling, ...
(Date:6/17/2013)... zuChem Inc., a leading producer of ... today that the United States Patent and Trademark ... 8,367,346 entitled “Methods for Production of Xylitol in ... D-Mannitol." These two patents expand zuChem's technology portfolio ... products from abundant, renewable feedstocks. , The ...
Breaking Biology Technology:MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2zuChem Receives Two Polyol Patents 2
... W.Va. Recent studies conducted at Marshall University have demonstrated ... used to increase the fuel efficiency of automobile engines -- ... this process is associated with liver damage. The ... his colleagues at Marshall,s Center for Diagnostic Nanosystems indicate there ...
... Nov. 17, 2011 Today BioSpace , the ... 2011-2012 BioForest™ Hotbed Campaign , marking the 7th ... The campaign highlights leading organizations across the ... is added to an electronic and printed campaign ...
... Builders, an award-winning general contractor specializing in a wide ... selected by the Los Angeles Biomedical Research Institute at ... of the initial phase for the creation of a ... 72-acre Harbor-UCLA Medical Center in Torrance, California.  Webcor will ...
Cached Biology Technology:Marshall study shows nanoparticles used as additives in diesel fuels can travel from lungs to liver 2BioSpace Spotlights Northwest's Life Science Community 2Webcor Builders Selected as the General Contractor for First Phase of LA BioMed's New Campus Master Plan 2Webcor Builders Selected as the General Contractor for First Phase of LA BioMed's New Campus Master Plan 3
(Date:6/18/2013)... extract of a yellow-flowered mountain plant long used for ... fruit fly populations by an average of 24 percent, ... Rhodiola rosea , also known as ... study leaders Mahtab Jafari and Sam Schriner. They discovered ... unrelated to dietary restriction and affects different molecular pathways. ...
(Date:6/18/2013)... of Adelaide shows that weight gain and increased head size ... a higher IQ at early school age. , The study was ... from more than 13,800 children who were born full-term. , The ... that babies who put on 40% of their birthweight in the ... time they were six years of age, compared with babies who ...
(Date:6/17/2013)... LA JOLLA, CA June 17, 2013 An ... Institute (TSRI), the Howard Hughes Medical Institute and Albert ... a highly promising new anti-tuberculosis compound that attacks the ... findings represent an effort to help solve one of ... of TB and its dangerous drug-resistant strains," said Peter ...
Breaking Biology News(10 mins):Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2IQ link to baby's weight gain in first month 2New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4
... common cause of pain and disability and ... and hip fractures. Yet there is evidence that ... fractures in their patients. Even if the fractures ... The Vertebral Fracture Initiative, available at ...
... 9, 2011 MaxID Pty Ltd, a wholly owned company ... is pleased to announce that it has won a 1000-unit ... "MaxID, with its distribution partner, Pinnacle Technology Holdings Ltd Group, ... Africa market.  Our iDL500, which is an incredibly proven device ...
... researchers have designed a new tool for identifying protein ... Ekker, Ph.D., succeeded in switching individual genes off and ... The study appears in the journal Nature Methods ... health-related problems such as how cancerous cells spread, what ...
Cached Biology News:New IOF teaching tool helps health professionals identify vertebral fractures 2MaxID Lands Sale of 1000 iDL500 Multi-Modal Handheld Identity Devices in South Africa 2In a genetic research first, Mayo Clinic turns zebrafish genes off and on 2In a genetic research first, Mayo Clinic turns zebrafish genes off and on 3
15(S)-HETE-d8 is used as an internal standard for the quantification of 15(S)-HETE by stable isotope dilution mass spectrometry....
...
...
All-in-one mix, removes primers and dNTPs from PCR product for following direct sequencing...
Biology Products: